Bloomberg Talks

Johnson & Johnson CFO Joseph Wolk Talks Earnings

Apr 16, 2024
Guest
Joseph Wolk
Johnson & Johnson CFO Joseph Wolk discusses Q1 earnings, forecast, and product pipeline. Highlights include adjusted profit guidance, strong growth in pharmaceuticals & MedTech, new drug replacements, successful products like Trampia, recent acquisitions, and financing strategies for future growth.
Ask episode
Chapters
Transcript
Episode notes
1
Johnson & Johnson's Q1 Performance and Strategic Update
00:00 • 5min
2
Exploring Replacement of Best-Selling Drug and Future Growth Strategies
04:38 • 6min